Researchers have identified MEK4 as a pro-invasion protein and the target for genistein, a dietary compound, in prostate cancer cells, according to a new study published online July 28 in the Journal of the National Cancer Institute. Li Xu, M.D., Ph.D., and Raymond C. Bergan, M.D.